AstraZeneca PLC is in talks to settle a Texas lawsuit claiming the company fleeced the state’s Medicaid program by fraudulently marketing one of its top drugs, according to court filings.
Texas sued the drugmaker in 2013, saying AstraZeneca had targeted the state’s Medicaid program by urging doctors to prescribe the powerful antipsychotic Seroquel for unauthorized treatments — particularly for children — over six years.
Source: Drugmaker seeks to settle claims it fleeced Texas’ Medicaid program / The Dallas Morning News